C5a immunotherapeutic (Resistentia)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameC5a immunotherapeutic (Resistentia)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC5a anaphylatoxin chemotactic receptor antagonists
TargetsC5a anaphylatoxin chemotactic receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesResistentia Pharmaceuticals Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesResistentia Pharmaceuticals Ab
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A